Breaking News, Collaborations & Alliances

Charles River and Valo Unveil Logica AI-Powered Drug Solution

Directly translates clients’ biological insights into optimized preclinical assets.

Author Image

By: Charlie Sternberg

Associate Editor

Charles River Laboratories International Inc. and Valo Health Inc. (Valo) have launched Logica, an artificial intelligence (AI) powered drug solution that directly translates clients’ biological insights into optimized preclinical assets.   Logica leverages Valo’s AI-powered Opal Computational Platform and Charles River’s leading preclinical expertise, providing clients with transformed drug discovery with a single integrated offering seamlessly translating targets to candidate nomination.   ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters